Global Rosacea Epidemiology Analysis & Forecast 2016-2018 & 2027 - ResearchAndMarkets.com
The "Rosacea - Epidemiology Forecast-2027" report has been added to ResearchAndMarkets.com's offering.
The total prevalent population of Rosacea was found to be 47,359,758, in the year 2016.
Rosacea - Epidemiology Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Rosacea in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Rosacea market report gives the thorough understanding of the Rosacea by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Rosacea in the US, Europe, and Japan.
The Rosacea epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented by Prevalent population, Gender specific prevalence, Diagnosed prevalent population, Sub-type specific diagnosed prevalence and Severity-Specific diagnosed prevalence] scenario of Rosacea in the 7MM.
Key Topics Covered:
1. Key Insights
2. Rosacea: Market Overview at a Glance
3. Disease Background and Overview: Rosacea
4. Epidemiology and Patient Population
5. 7MM Total Prevalent Patient Population of Rosacea
6. 7MM Total Diagnosed Prevalent Patient Population of Rosacea
7. Country Wise-Epidemiology of Rosacea Disease
For more information about this report visit https://www.researchandmarkets.com/research/3bwgmd/global_rosacea?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005326/en/